Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | ACLX | PTGX | ||
| Company | Repligen Corp | Arcellx Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 118.60 | 114.69 | 100.00 | ||
| High | 122.00 | 114.78 | 102.06 | ||
| Low | 116.22 | 114.47 | 98.15 | ||
| Latest | 116.35 | 114.60 | 98.54 | ||
| Change | +2.47 | -0.17 | -0.33 | ||
| % Change | +2.17% | -0.15% | -0.33% | ||
| Volume | 819,800 | 1,958,200 | 925,400 | ||
| 20-Day Average Volume | 987,410 | 3,331,725 | 923,555 | ||
| Previous Close | 113.88 | 114.77 | 98.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 122.24 | 114.27 | 94.35 | ||
| 20-Day Raw Stochastic | 14.39% | 75.97% | 64.41% | ||
| 20-Day Relative Strength | 36.08 | 78.82 | 60.76 | ||
| Weighted Alpha | -18.17 | +15.13 | +85.28 | ||
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 72% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 64% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 03/16/26 | +0.08% since 03/16/26 | +1.85% since 03/16/26 | ||
| Low | 113.63 on 03/20/26 | 114.30 on 03/19/26 | 90.58 on 03/18/26 | ||
| High | 122.62 on 03/17/26 | 114.91 on 03/20/26 | 105.69 on 03/19/26 | ||
| 1-Month | |||||
| %Chg | -14.07% since 02/23/26 | +0.75% since 02/23/26 | +13.80% since 02/23/26 | ||
| Low | 112.47 on 03/12/26 | 113.62 on 02/25/26 | 85.60 on 02/26/26 | ||
| High | 139.43 on 02/24/26 | 114.91 on 03/20/26 | 105.69 on 03/19/26 | ||
| 3-Month | |||||
| %Chg | -30.06% since 12/23/25 | +74.94% since 12/23/25 | +11.06% since 12/23/25 | ||
| Low | 112.47 on 03/12/26 | 60.35 on 01/05/26 | 77.00 on 02/23/26 | ||
| High | 175.77 on 01/06/26 | 114.91 on 03/20/26 | 105.69 on 03/19/26 | ||
| 6-Month | |||||
| %Chg | -6.13% since 09/23/25 | +44.79% since 09/23/25 | +51.46% since 09/23/25 | ||
| Low | 112.47 on 03/12/26 | 60.35 on 01/05/26 | 62.24 on 10/07/25 | ||
| High | 175.77 on 01/06/26 | 114.91 on 03/20/26 | 105.69 on 03/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,554,112 | 6,701,806 | 6,287,738 | ||
| Shares Outstanding, K | 56,331 | 58,480 | 63,809 | ||
| Annual Sales | 738,260,000 | 22,290,000 | 46,020,000 | ||
| Annual Net Income | 48,890,000 | -228,930,000 | -130,150,000 | ||
| Last Quarter Sales | 197,910,000 | 1,650,000 | 7,440,000 | ||
| Last Quarter Net Income | 13,290,000 | -58,110,000 | -44,380,000 | ||
| 60-Month Beta | 1.15 | 0.22 | 2.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/24/26 | -1.01 on 02/26/26 | -0.69 on 02/25/26 | ||
| Latest Earnings Date | 05/05/26 | 05/14/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 66.60 | 0.00 | 0.00 | ||